Highlights and Quick Summary
- Shareholders Equity per Share for the quarter ending October 31, 2022 was 0.66 (a -0.53% decrease compared to previous quarter)
- Year-over-year quarterly Shareholders Equity per Share decreased by -77.91%
- Annual Shareholders Equity per Share for 2022 was 0.67 (a -89.11% decrease from previous year)
- Annual Shareholders Equity per Share for 2021 was 6.12 (a -221.5% decrease from previous year)
- Annual Shareholders Equity per Share for 2020 was -5.04 (a 357.02% increase from previous year)
Visit stockrow.com/BCTX
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Shareholders Equity per Share of BRIACELL THERAP
Most recent Shareholders Equity per Shareof BCTX including historical data for past 10 years.Interactive Chart of Shareholders Equity per Share of BRIACELL THERAP
BRIACELL THERAP Shareholders Equity per Share for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | 0.66 | 0.67 | 3.0 | 3.0 | 0.67 |
| 2021 | 3.63 | 6.12 | 2.91 | -4.67 | 6.12 |
| 2020 | -4.38 | -5.04 | -3.85 | -3.15 | -5.04 |
| 2019 | -353.0 | -1.11 | 1.17 | -1.17 | -1.1 |
| 2018 | 0.69 | 2.74 | 5.69 | 1.24 | 2.26 |
| 2017 | 2.76 | -4.21 | 4.76 | 4.05 | 2.1 |
| 2016 | 5.41 | -5.52 | 3.89 | 1.9 | 2.72 |
| 2015 | 3.1 | -9.83 | 5.37 | 8.99 | 5.08 |
| 2014 | 3.5 | -8.0 | 42.14 | 46.23 | 4.01 |
| 2013 | 48.3 | -99.36 | 50.39 | 52.41 | 50.1 |
| 2012 | 52.98 | -106.87 | 56.1 | – | 52.67 |
Business Profile of BRIACELL THERAP
Sector: Healthcare
Industry: Biotechnology